TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/22/23 17:32 | 12/20/23 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Trevejo Jose M. | CA | O | CHIEF ME | S | -45 | 20.00 | 0 | -2 | -50 | 2 | D | ||||||||||||||
10/6/23 17:21 | 10/5/23 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Trevejo Jose M. | CA | O | CHIEF ME | S | -29 | 18.00 | 0 | -2 | -26 | 5 | D | ||||||||||||||
3/23/23 20:02 | 3/21/23 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Trevejo Jose M. | CA | O | CHIEF ME | S.m | -19 | 12.58 | 0 | -2 | -20 | 6 | D | ||||||||||||||
3/21/23 19:10 | 3/17/23 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Trevejo Jose M. | CA | O | CHIEF ME | S.m | -13 | 12.94 | 0 | -1 | -12 | 8 | D | ||||||||||||||
3/17/23 18:18 | 3/15/23 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Trevejo Jose M. | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 8 | 683 | 9 | D | ||||||||||||||
3/17/23 18:18 | 3/16/23 | TARS | Tarsus Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Trevejo Jose M. | CA | O | Chief Me | S.d | -7 | 13.43 | 0 | 0 | -5 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |